BioInfra faces KOSDAQ delisting risk after failing 20 billion won market-cap test

KOSDAQ delisting risk grows for BioInfra after it was flagged with an “administrative issue” on July 31 for 30 straight sessions below the KRW 20 billion market-cap threshold. As of Sept. 30 it had 0 consecutive days at or above KRW 20 billion versus 45 days needed to lift the designation; delisting risk escalates if market cap stays below KRW 20 billion for five consecutive trading days.